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Ras GTPases were long thought to function exclusively from the plasma membrane (PM). However, a
current model suggests that Ras proteins can compartmentalize to regulate different functions, and an
oncogenic H-Ras mutant that is restricted to the endomembrane can still transform cells. In this study, we
demonstrated that cells transformed by endomembrane-restricted oncogenic H-Ras formed tumors in nude
mice. To define downstream targets of endomembrane Ras pathways, we analyzed Cdc42, which concentrates
in the endomembrane and has been shown to act downstream of Ras in Schizosaccharomyces pombe. Our data
show that cell transformation induced by endomembrane-restricted oncogenic H-Ras was blocked when Cdc42
activity was inhibited. Moreover, H-Ras formed a complex with Cdc42 on the endomembrane, and this
interaction was enhanced when H-Ras was GTP bound or when cells were stimulated by growth factors. H-Ras
binding evidently induced Cdc42 activation by recruiting and/or activating Cdc42 exchange factors. In contrast,
when constitutively active H-Ras was restricted to the PM by fusing to a PM localization signal from the Rit
GTPase, the resulting protein did not detectably activate Cdc42 although it activated Raf-1 and efficiently
induced hallmarks of Ras-induced senescence in human BJ foreskin fibroblasts. Surprisingly, PM-restricted
oncogenic Ras when expressed alone could only weakly transform NIH 3T3 cells; however, when constitutively
active Cdc42 was coexpressed, together they transformed cells much more efficiently than either one alone.
These data suggest that efficient cell transformation requires Ras proteins to interact with Cdc42 on the
endomembrane and that in order for a given Ras protein to fully transform cells, multiple compartment-
specific Ras pathways need to work cooperatively.
Ras GTPases cycle between GDP- and GTP-bound states,
and when they are GTP bound, they stimulate downstream
effectors to regulate a wide range of signal transduction path-
ways (16). Ras activation is dependent on guanine nucleotide
exchange factors (GEFs), and Ras inactivation is accelerated
by GTPase activating proteins (GAPs). While Ras proteins are
perhaps best known for their ability to mediate growth factor
signaling to promote proliferation, deregulation of which
causes cell transformation and tumorigenesis, Ras proteins
also regulate many antiproliferative activities, such as apop-
tosis, differentiation, and senescence. How Ras proteins can
regulate different functions with selectivity is of great impor-
tance but poorly understood.
In mammals, there are three RAS genes, H-RAS, N-Ras, and
K-RAS. Their gene products are highly similar at the N termini,
which contain the major binding sites for effectors. Not sur-
prisingly, in vitro, these Ras proteins can all efficiently interact
with many effectors. Despite this, there is evidence that in vivo
Ras proteins may control different functions. For example, in
mice, when the WNT1 oncogene is overexpressed in the mam-
mary gland, the resulting tumors frequently contain H-RAS
mutations (31); in contrast, K-RAS mutations are frequently
detected when breast tumors are induced by MYC (7). In
humans, most RAS mutations in tumors are in K-RAS, whereas
H-RAS and N-RAS mutations are restricted to tumors of cer-
tain tissues (16). Furthermore, different Ras isoforms are se-
lectively overexpressed in different subtypes of breast tumors.
For example, H-RAS is selectively upregulated in luminal B
and HER2/ER subtypes of human breast cancer, while N-
RAS is upregulated in the basal-like subtype (10).
To decipher how Ras proteins can control different func-
tions, one approach focuses on their C termini, the most di-
vergent regions in these proteins (called the hypervariable re-
gion [HVR]). The C termini of Ras proteins undergo various
lipidations, which play key roles in mediating protein subcel-
lular localization (30, 55). All Ras proteins contain a CAAX
motif, the cysteine residue of which can be farnesylated to
allow association with the endomembrane (EM). However,
association with the plasma membrane (PM) differs among
Ras proteins: K-Ras4B associates with the PM via its polylysine
residues, while H- and N-Ras do so via palmitoylation at their
cysteine residues immediately upstream of the CAAX box.
These different modes of PM association appear to affect
where these proteins are found in the cell; at steady state, while
N- and H-Ras can be readily detected on the PM as well as the
endomembrane (e.g., Golgi compartment), K-Ras4B is nearly
exclusively found on the PM. These observations support a
model whereby Ras proteins can control different functions by
localizing to different compartments.
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One of the earliest tests of this model came when Hancock
et al. (8) demonstrated that expression of an oncogenic H-Ras
that is restricted to the endomembrane (e.g., by mutating its
two cysteine residues for palmitoylation to serine) can trans-
form NIH 3T3 cells (8), which was also later confirmed in a
more detailed study (5). These observations suggest that the
endomembrane can be a productive compartment from which
Ras proteins can signal to induce cell transformation. How-
ever, it was unclear with which endogenous effectors Ras pro-
teins interact on the endomembrane and whether cells trans-
formed by endomembrane-restricted Ras are tumorigenic. We
have recently further investigated this model in the fission
yeast Schizosaccharomyces pombe, which unlike most mamma-
lian cells has just one Ras protein, called Ras1. Our data show
that Ras1 clearly compartmentalizes to activate two separate
downstream pathways: PM-restricted Ras1 selectively activates
a mitogen-activated protein (MAP) kinase module to regulate
mating, while endomembrane-restricted Ras1 activates Cdc42
to regulate morphogenesis, transport, mitosis, and proteasome
functions (3, 30). Cdc42 in mammalian cells is well docu-
mented to play a role in trans-Golgi network transport by
regulating vesicle trafficking (1), and one of its effectors is
COP- (56), a vesicle coat protein. Furthermore, overexpress-
ing a dominant negative Cdc42 [Cdc42(17N)] can block Ras-
induced cell transformation (33, 39). It thus seems likely that
Ras can also act via Cdc42 on the endomembrane in mamma-
lian cells to influence cell transformation.
In this study, we show that cells transformed by endomem-
brane-restricted oncogenic H-Ras efficiently form tumors in
immunodeficient mice. We further present evidence that upon
growth factor stimulation, activated H-Ras can turn on a
Cdc42 pathway on the endomembrane, which is critical for
transformation. H-Ras appears to activate Cdc42 by recruiting
its GEF. In contrast, when activated H-Ras is restricted to the
PM, it does not activate Cdc42 although it can fully activate
Raf-1 and induce senescence in human primary cells. Intrigu-
ingly, the PM-restricted oncogenic H-Ras can transform NIH
3T3 cells only weakly by itself, but when constitutively active
Cdc42 is coexpressed, together they transform cells much more
efficiently than either one alone. These results suggest that
H-Ras can act via Cdc42 on the endomembrane to transform
cells and that this and other compartment-specific pathways
need to operate in a concerted manner to efficiently transform
cells.
MATERIALS AND METHODS
Cells and cell culture. NIH 3T3 and BJ cells were purchased from the Amer-
ican Type Culture Collection (ATCC, Manassas, VA) and cultured according to
ATCC protocols. HTC75 and 293FT (Invitrogen, Carlsbad, CA) cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum and 2 mM L-glutamine. All transfection experiments
were performed with Lipofectamine 2000 (Invitrogen). To create NIH 3T3 cells
stably expressing both Cdc42(12V) and PM-Ras(61L), NIH 3T3 cells were trans-
fected with either pcDNA-MYC-Cdc42(12V) or vector control and then grown
in medium containing G418 (500 g/ml) for 3 days. The selected G418-resistant
cells were then infected twice with either vector control or pLenti4-PM-
Ras(61L)-puro and further selected by puromycin (1 g/ml). The resulting G418
and puromycin dually resistant cells were pooled. Western blotting showed that
levels of Cdc42(12V) and PM-Ras(61L) in cells that expressed both proteins
were comparable to those of cells in which only one of the proteins was expressed
(data not shown).
Plasmid construction. The C-terminal PM localization signal from Rit (Rit-C)
(30) was fused to the 3 coding sequence of H-Ras(61L,186S) by two rounds of
PCR using pcDNA-H-Ras(61L,186S) (5) and pEGFP-Rit (where EGFP is en-
hanced green fluorescent protein) (30) as templates and the following primers
(5-3): the primer pair ATGACGGAATATAAGCTGGTGGTGGTGGGC
and GTATGCAGCAGATGTCTCAAAAAAGGGACAGGAGAGCACAGA
CTTGCAGCTCATGCAGCC and the pair GGCTGCATGAGCTGCAAGTC
TGTGCTCTCCTGTCCCTTTTTTGAGACATCTGCTGCATAC and TCAAG
TTACTGAATCTTTCTTCTTCCGG. The resulting DNA fragment was
subcloned into pcDNA at the HindIII and KpnI sites to generate pcDNA-PM-
Ras(61L). To generate pcDNA-MYC-Cdc42, a DNA fragment was released by
EcoRV and XbaI from pUM-Cdc42(12V) (38) to replace the same fragment in
pcDNA-Cdc42(28L) (23). To construct pcDNA-Cdc42(17N), a DNA fragment
encoding Cdc42(17N) was released from pUM-Cdc42(17N) (38) by EcoRI and
XbaI and cloned into pcDNA. The DNA fragments encoding the H-Ras(12V),
H-Ras(61L), EM-H-Ras(61L), PM-Ras(61L), Cdc42, Cdc42(17N), Raf-1 con-
taining just the Ras binding domain (RafRBD), Raf-1, and RIN1 were amplified
by PCR (Accuzyme, Bioline, Taunton, MA) using pM4-IRES-GFP-H-Ras(12V)
(where IRES is internal ribosome entry site) (M. Thai and J. Colicelli, unpub-
lished results), pcDNA-H-Ras(61L) (5), pcDNA-H-Ras(61L,181S,184S) (5),
pcDNA-PM-Ras(61L), pcDNA-MYC-Cdc42, pcDNA-Cdc42(17N), pEYFP-
RafRBD (5), pDONR223-Raf-1 (41), and pKS-RIN1 (11), respectively, as tem-
plates. All PCR forward primers start with the CACC sequence right before the
start codon, allowing them to be ligated to linearized pENTR-Direct-TOPO by
the Directional TOPO cloning system (Invitrogen). The resulting vectors were
used as entry vectors to N-terminally tag proteins with GFP, mCherry, yellow
fluorescent protein (YFP), cyan fluorescent protein (CFP), or FLAG by the
Gateway system (Invitrogen) using pCL-GFP-DEST, pCL-mCherry-DEST,
pCL-YFP-DEST, pCL-CFP-DEST, or pCL-FLAG-DEST, respectively, as the
destination vectors. To express various H-Ras proteins in a lentiviral vector,
pLenti4-DEST (Invitrogen) was used as the destination vector. The short hairpin
RNA (shRNA) vectors that silence CDC42 expression and their nontargeting
control (pLKO-non-target) are from Sigma (St. Louis, MO), and clones 1 and 2
used in this study contain the following sequences (5-3): CGGAATATGTAC
CGACTGTTT and CCTGATATCCTACACAACAACC. The pcDNA-MYC-
Cdc42* construct was created by site-directed mutagenesis (Stratagene, La Jolla,
CA) on pcDNA-MYC-Cdc42 using the following primer set (5-3): GTTGGTAA
AACATGTCTACTTATCTCATATACGACTAACAAATTTCCATCG and CG
ATGGAAATTTGTTAGTCGTATATGAGATAAGTAGACATGTTTTACC
AAC. This vector expresses Cdc42*, which is refractory to shRNA 2. To mutate
the cysteine in the CAAX box of LCK-H-Ras(12V,181/4S) (26), site-directed
mutagenesis was performed on pEF-LCK-H-Ras(12V,181/4S) using the primer
set (5-3) AGCATGAGCAGCAAGAGTGTGCTCTCCTGACGC and GCGT
CAGGAGAGCACACTCTTGCTGCTCATGCT to create pEF-LCK-H-
Ras(12V,181/4/6S). pRK5-FLAG-ITSN1-L and pEGFP-ITSN1-L were kindly
provided by Peter McPherson (McGill University). Src(527F) (46) was fused at
the C terminus with Rit-C by two rounds of PCR and subcloned to pMSCV
(where MSCV is mouse stem cell virus) (Clonetech, Mountain View, CA) at the
BglII and EcoRI sites. The vector that expresses the shRNA (5-3) CCAGCA
GAATGATGAAAAGCAA against Dbl was obtained from OpenBiosystem. All
PCR and mutagenized DNAs were confirmed by sequencing.
Virus production and infection. Viral vectors were produced in 293FT cells by
cotransfecting packaging vectors (pAmpho for retrovirus, and pLP1, pLP2, and
pVSVG [where VSVG is vesicular stomatitis virus G protein] for lentivirus)
together with appropriate vectors to express various proteins. The supernatant
containing the virus was harvested and filtered 48 h after transfection. The viral
infection was carried out with 4 (retrovirus) or 6 (lentivirus) g/ml of Polybrene
(Calbiochem, San Diego, CA) for 16 h, and then the cells were fed with fresh
medium for another 24 h before antibiotic selection. The titer of the virus used
in the soft agar assay was determined following Invitrogen protocols.
Immunoblotting. Proteins were separated by SDS-PAGE and transferred to
the nitrocellulose membrane (Bio-Rad, Hercules, CA). To detect Ras, the pan-
reactive Ras10 antibody (Calbiochem) was used (1:300). The antibodies that
recognize FLAG (M2 clone; 1:1,000) and GFP (1:2,000) were from Sigma and
Fitzgerald (Concord, MA). Antibodies against Na/K ATPase (1:500) and
caveolin (1:500) were from BD Biosciences (San Jose, CA), while Cdc42 (1:500)
and p53 (1:1,000) antibodies were from Santa Cruz (Santa Cruz, CA). The MYC
tag was recognized by the 9E10 monoclonal antibody (hybridoma cell culture
medium; 1:10). Antibodies against p42/44 Erk kinase, phospho-p42/44 Erk ki-
nase, p38 MAP kinase, and phospho-p38 MAP kinase were all purchased from
Cell Signaling (Danvers, MA). The fluorescein-conjugated secondary antibodies
(1:10,000) were purchased from Li-COR Biosciences (Lincoln, NE), and the
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protein levels were quantified by the Odyssey Infrared Imaging System (Li-COR
Biosciences).
Statistics. After quantifications, values are shown as averages  standard
errors of the means (SEM). Unpaired student t tests were performed to obtain
P values.
Cell transformation assays. To perform the focus formation assay, NIH 3T3
cells at 60% confluence (in a 60-mm dish) were transfected and split into four
60-mm dishes 48 h posttransfection. One dish of cells was lysed with SDS sample
buffer for protein expression analysis, and the rest were grown for 14 more days
before being stained by crystal violet (0.5% in 20% ethanol) to visualize foci. To
compensate for low expression of PM-Ras(61L), 10 times more vector DNA was
used. To carry out the soft-agar colony formation assay, NIH 3T3 cells were
transfected with vectors to express various H-Ras proteins and selected in the
presence of G418 (500 g/ml). For each vector, a total of 10 clones (clones 1 to
10) were confirmed to express H-Ras proteins at similar levels, and three of them
were used for this experiment. These cells were infected by pCL-FLAG-
Cdc42(17N) with increasing dosages (10, 20, and 40 multiplicities of infection).
Forty-eight hours after infection, they were trypsinized, and growth medium was
added immediately when cells began to detach. Approximately 5 104 cells were
mixed with SeaPlaque agar such that the final agar concentration was 0.35%.
This mixture was loaded into a 60-mm dish containing 0.7% SeaPlaque agar. For
the study involving coexpression of PM-Ras(61L) and Cdc42(12V), 1  104 cells
were used and seeded in six-well plates. These cells were cultured for 14 to 28
days and fed every 4 days with 250 l of the same medium as described above
except that it contained 30% calf serum. They were finally incubated with 0.1%
(wt/vol) 3-(4,5-dimethylthiazol-2-yl)2 2,5-diphenyl tetrazolium bromide (MTT;
Sigma) in PBS to visualize colonies.
The BiFC assay. HTC75 cells were chosen for the bimolecular fluorescence
complementation (BiFC) assay for their low background fluorescence in fluo-
rescence-activated cell sorting (FACS) (our unpublished results). We fused pro-
teins of interest to the C and N termini of YFP fragments (Yc and Yn, respec-
tively). While such fusion proteins worked well in this assay, we became aware
that a mutant version of YFP called Venus is much brighter than the wild-type
form in part because of mutations in the N terminus (28). We thus used the N
terminus from Venus (amino acids 1 to 155) for this study, while Yc contains
amino acids 156 to 239 from wild-type YFP. To express them, pBabe-Yn-DEST-
Neo and pBabe-Yc-DEST-Puro (4) were used as destination vectors for the
Gateway cloning system. The DNA fragments encoding H-RasE(12V) and
EM-H-RasE(12V) were generated by two rounds of site-directed mutagenesis
(Stratagene) using either pENTR-H-Ras(12V) or pENTR-EM-H-Ras(12V) as a
template and the primer set (5 to 3) CCATTTTGTGGACGAAGCCGCCGC
CGCTGTAGAGGATTCCTACCGG and CCGGTAGGAATCCTCTACAGC
GGCGGCGGCTTCGTCCACAAAATGG and the set AATGACCACCTGCT
TCCGGGCGGCAGCCGCTGCAGCGGCGGCGGCTT and AAGCCGCCG
CCGCTGCAGCGGCTGCCGCCCGGAAGCAGGTGGTCATT to mutate
amino acids 32 to 40 in the effector loop of H-Ras to alanine. HTC75 cells were
infected with vectors encoding Yn-tagged H-Ras proteins and then selected with
G418 (500 g/ml). For each vector, three clones of cells expressing H-Ras
proteins at similar levels were pooled. These cells were then infected by retroviral
vectors expressing Yc-tagged proteins and selected in puromycin (1 g/ml)
medium. The samples were examined by either FACS or confocal microscopy.
Effector pulldown assay for Cdc42 activation. The BL21(DE3) Escherichia coli
strain was transformed using pGEX fused to Cdc42/Rac interactive binding
(CRIB) domain of PAK1 (pGEX-PAKCRIB) (25), and glutathione S-transferase
(GST)-PAKCRIB expression was induced by isopropyl-	-D-thiogalactopyranoside
(IPTG). The cells were washed with phosphate-buffered saline (PBS) and then
lysed with PBS containing Triton X-100 (0.1%) and lysozyme (1 mg/ml). The
lysate was cleared by centrifugation. GST-PAKCRIB beads were prepared using
the glutathione resin (Clontech, Mountain View, CA), and the final concentra-
tion of GST-PAKCRIB was 200 ng/l. Mammalian cells were lysed in 25 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP-40, 1 mM dithiothreitol
(DTT), and 5% glycerol, and the resulting lysate (500 g of protein) was mixed
with 100 l of GST-PAKCRIB resin for 1 h at 4°C with rocking. The resin was
washed three times with lysis buffer, and the bound Cdc42 was subsequently
eluted by 50 l of 2 SDS sample buffer and finally resolved by 15% SDS-
PAGE.
IP. Cells were lysed in immunoprecipitation (IP) buffer (15), supplemented
with protease inhibitors (Roche Applied Science, Indianapolis, IN). Cell lysates
were precleared with mouse IgG-conjugated beads (A0919; Sigma) for 4 h with
agitation at 4°C. The cleared lysates were incubated with either Ras10 antibody
or anti-FLAG antibody-conjugated beads (M2 clone; Sigma) overnight with
agitation at 4°C. Protein A-agarose beads (Roche Applied Science) were added
to samples treated with the Ras10 antibody or mouse IgG (at 4°C with agitation
for 4 more hours). The beads were then washed four times with Tris-buffered
saline (TBS) buffer, and the bound materials were eluted with 50 l of 2 SDS
sample buffer and resolved by 15% SDS-PAGE. Epidermal growth factor
(EGF)/serum-stimulated cells were similarly lysed in the same buffer supple-
mented with additional phosphatase inhibitors (1 mM NaVO3 and 1 mM NaF).
Immunostaining. Cells were seeded onto fibronectin-coated coverslips (BD)
at 24 h posttransfection and were fixed 16 h later with 4% paraformaldehyde (20
min at room temperature). The fixed samples were sequentially incubated with
50 mM ammonium chloride-PBS (10 min at room temperature), permeabilized
in PBS containing 0.1% Triton X-100 and 200 mM glycine (10 min at 4°C), and
blocked with 3% bovine serum albumin (1 h at room temperature). All samples
were incubated with the Ras10 antibody overnight at 4°C and then with the Alexa
Fluor 488-conjugated secondary antibody (Invitrogen) for 1 h at room temper-
ature. All samples were mounted using mounting medium containing 4,6-
diamidino-2-phenylindole (DAPI; Vector Lab, Burlingame, CA).
FACS and microscopy. FACS was performed using an EPICS XL-MCL in-
strument (Beckman-Coulter, Fullerton, CA), and results were analyzed by the
WinMDI software. For live-cell microscopy, cells were grown on glass-bottom
plates (MatTek Corp., Ashland, MA). To perform deconvolution microscopy,
cells were imaged with an Olympus IX70 microscope equipped with 60/1.4 oil
objective and a Retiga 1300R camera (Q-Imaging, Surrey, British Columbia,
Canada). Stacks of 14 images at 0.5-m intervals were deconvolved by Slidebook
(Intelligent Imaging Innovations, Denver, CO). Confocal microscopy was per-
formed on a Leica TCS SP5 microscope with a 63/1.4 oil objective. To image
the BiFC samples, its Ar and He/Ne lasers were operated at 30 and 100% power,
respectively. CFP (458 nm) was detected with 48% of available Ar laser
power, while YFP (514 nm) was imaged with 52% of the available He/Ne laser
power. The samples were scanned at 700 Hz, signals from two consecutive line
scannings were accumulated, and the whole frame was averaged once to reduce
background. For regular confocal experiments, the 405-nm and He/Ne laser were
turned on at full power while the Ar laser was set at 30% power. To visualize
DAPI and YFP, 40% 405-nm and 52% He/Ne available laser power was used. To
image CFP and Alexa Fluor 488, 48% and 30% Ar available laser power was
used. All confocal images were analyzed by the Leica LAS AF software. To
quantify the efficiency of protein localization to the PM, a region of interest
(ROI) was first created to measure the fluorescent intensity of the whole cell
(ROIw). A second ROI, was created to measure the signal in the cytoplasm
(ROIc). The signal at the PM is defined as ROIw  ROIc.
Sucrose gradient cell fractionation. NIH 3T3 cells were scraped and washed
with PBS and resuspended and lysed in 0.5 M Na2CO3 as described previously
(32). The cell lysate was centrifuged at 
220,000  g in a 5 to 45% sucrose
gradient. Thirteen fractions of 400 l each were collected, and an equal volume
of each fraction was examined by Western blotting.
Raf-1 recruitment assay. When CFP-Raf-1 was examined, various H-Ras
proteins were YFP tagged to allow identification of cells that also express the
tested H-Ras proteins. At 24 to 36 h after transfection, cells were serum starved
for 1 h before imaging. Only cells that expressed both YFP and CFP were
analyzed. The efficiency of Raf-1 recruitment to the PM was determined by
measuring the portion of CFP-Raf-1 at the PM over the total CFP signal in the
cell, as described above in “FACS and microscopy.” This study also examined
various H-Ras proteins that were tagged by LCK using YFP-RafRBD. These
LCK-tagged H-Ras proteins may not be further tagged without affecting proper
localization because they already contain a myristoylation signal at the N termi-
nus and a CAAX motif at the C terminus. Thus, in the doubly transfected cells,
we could observe only YFP signal from YFP-RafRBD, which occurred in 50 to
60% of these cells. When cells were cotransfected by the vector control, nearly
all YFP-positive cells showed diffused YFP signal. In contrast, when different
LCK-tagged H-Ras mutants were expressed, about 20% of the YFP-positive cells
displayed nondiffused YFP. In comparison, 40 to 50% of YFP-positive cells
showed nondiffused YFP when unrestricted H-Ras(61L) was expressed. Nine to
20 such cells from each sample were chosen to further analyze whether YFP-
RafRBD was preferentially recruited to the PM or to the internal membranes in
the cytoplasm, as described above.
Raf-1 kinase activity measurement. A Raf-1 kinase experiment was performed
as described previously (40). Briefly, transfected 293FT cells were serum starved
and lysed, and the lysate was centrifuged at 100,000  g to yield the supernatant
(S100) and pellet (P100). The pellet was resuspended in the lysis buffer at the
same volume as the supernatant to yield the P100 fraction. The presence of Raf-1
in these fractions was analyzed by Western blotting. Ten micrograms of protein
from the P100 fraction was taken to measure Raf-1 activity using a MEK1/Erk2-
coupled in vitro kinase assay kit from Millipore (Billerica, MA). The phosphor-
ylated Erk2 was detected by Western blotting.
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Yeast two-hybrid assay. A yeast two-hybrid assay was performed as previously
described using the L40 reporter strain (2). The DNAs encoding H-Ras(61L),
EM-H-Ras(61L), and PM-Ras(61L) were cloned to pBluescript at the BamHI
and SacI sites by PCR. A BglII linker was added to the SacI site of the resulting
vectors, and then the DNA fragments encoding various H-Ras mutants were
released and subcloned to pVJL11 at the BamHI site. Plasmids pGAD424-AF6
(49), pGADGE-RalGDS (53), and pGAD-Raf-1 (52) were kind gifts from Mi-
chael White (University of Texas Southwestern Medical School). In these pGAD
vectors, the cDNAs encoding the tested Ras effectors were fused with the coding
sequences of the GAL4 activation domain and a nuclear localization signal from
simian virus 40 (SV40).
Senescence assay. BJ cells between population doublings 23 to 33 were in-
fected with the described lentiviral vectors to express various H-Ras mutants.
The virus was either used straight for infection [vector control, H-Ras(61L), and
EM-H-Ras(61L)] or concentrated by an Amicon Ultra-15 spin column (Milli-
pore) to compensate for the low expression level of PM-Ras(61L). Infected cells
were divided into two groups at 36 h postinfection. Cells in group 1 were serum
starved for 20 h and then lysed with IP buffer supplemented with protease and
phosphatase inhibitors as described previously (15) and analyzed by Western
blotting. Cells in group 2 were selected with zeocin (100 g/ml) for 12 days and
then stained with 5-bromo-4-chloro-3-indolyl-	-D-galactopyranoside (X-Gal)
and scored microscopically (15).
Tumorigenicity assay in nude mice. Female nu/nu mice (Harlan, Houston,
TX) at 6 to 7 weeks of age were divided into three groups of 8 animals each. The
three selected clones of cells were pooled and allowed to grow to approximately
80% confluence. They were then scraped and washed with PBS. Cell pellets were
resuspended in Hanks balanced salt solution (Invitrogen) at a density of 1 
106/ml, and 100 l of these cells was injected subcutaneously into the right flank
of each animal. Tumor volumes were measured 10 days after injection (44).
RESULTS
Inactivating Cdc42 blocks cell transformation induced by
endomembrane-restricted oncogenic H-Ras. To determine
whether endomembrane-restricted H-Ras requires Cdc42 to
transform cells, we sought to block Cdc42 activity and then
measure cell transformation as induced by endomembrane-
restricted H-Ras. We first screened commercially available
shRNAs and found two clones that are particularly efficient in
silencing Cdc42 expression without affecting expression of ac-
tin, H-Ras, and other Rho GTPases (RhoA and Rac) (Fig. 1A
and data not shown). These two shRNAs were expressed in
NIH 3T3 cell lines that stably express a constitutively active
H-Ras [H-Ras(61L,181S,184S)] whose two cysteine residues
for palmitoylation (5) have been mutated to serine to prevent
PM association (see Fig. S1 in the supplemental material). We
renamed it EM-H-Ras(61L) to denote its restriction to the
endomembrane. Our data show that when Cdc42 protein levels
were reduced by shRNA, cell transformation (Fig. 1B and C
show data for focus formation; data for colony formation in
soft agar are not shown) induced by EM-H-Ras(61L) was
blocked. We note that the efficiencies of shRNAs to block
EM-H-Ras(61L)-induced transformation correlated with those
of Cdc42 knockdown; further, overexpressing either normal
CDC42 or a mutant CDC42, CDC42*, that is refractory to the
CDC42 shRNA could restore cell transformation (Fig. 1D and
data not shown). These results suggest that these shRNAs
block Cdc42 expression with high specificity. To exclude the
possibility that CDC42 shRNA blocks cell growth indiscrimi-
nately, we determined that cells transfected by the shRNA
vector, which contains a puromycin resistance marker, could
efficiently form colonies in puromycin (data not shown). We
similarly examined a dominant negative Cdc42 [Cdc42(17N)]
and obtained the same results (data not shown).
To determine whether the “normal” unrestricted H-Ras(61L)
also required Cdc42 for cell transformation, we repeated these
experiments and found that cell transformation induced by the
unrestricted H-Ras(61L) protein was also inhibited by
Cdc42(17N) and Cdc42 shRNAs (Fig. 1). These data collectively
support the idea that endomembrane-localized H-Ras acts
through Cdc42 to transform cells.
Activated H-Ras forms a complex with Cdc42. To further
investigate how Ras interacts with Cdc42, we ascertained
whether H-Ras and Cdc42 formed a complex. We first per-
formed colocalization experiments examining ectopically ex-
pressed epitope-tagged proteins by confocal microscopy. Our
data show that these two proteins colocalize in a vesicular
structure near the nucleus (see Fig. S2 in the supplemental
material). We then employed the bimolecular fluorescence
complementation (BiFC) method, which takes advantage of
the fact that fusing the N- and C-terminal YFP fragments (Yn
and Yc, respectively) to two proteins that form a complex can
restore the YFP signal, detectable by both FACS and fluores-
cence microscopy (17). This method can detect transient and
weak protein-protein interactions because once a protein com-
plex is formed, it is very stable as the binding is secured by not
only the binding between the two proteins of interest but also
FIG. 1. Cdc42 inactivation blocks cell transformation induced by
endomembrane-restricted oncogenic H-Ras. (A) NIH 3T3 cells were
transiently cotransfected with pcDNA-H-Ras(61L) plus a vector car-
rying shRNA 1 or 2 against Cdc42 or a nontarget shRNA. Cells were
lysed with SDS sample buffer, and cell lysates were examined by West-
ern blotting to determine the efficiency of the knockdown and its
effects on Ras expression. Actin was the loading control. (B and C)
NIH 3T3 cells were cotransfected with vectors expressing either
H-Ras(61L) or EM-H-Ras(61L) and the indicated amount of Cdc42
shRNA 1 or 2. The mean numbers of foci were calculated from cells
seeded in triplicate (n  3), and the number of foci from cells express-
ing the nontarget shRNA was taken as 1. (D) NIH 3T3 cells were
transfected with vectors expressing either H-Ras(61L) or EM-H-
Ras(61L) together with either the vector control () or a vector
expressing Cdc42 shRNA 2 and with or without Cdc42*, which is
refractory to the shRNA knockdown (data not shown). Focus forma-
tion was assayed as described for panel B. A normal CDC42 cDNA was
similarly tested, which restored Cdc42 to endogenous levels, and the
same rescue results were obtained (data not shown).
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the very strong H-bonds formed between the N- and C-termi-
nal regions of YFP (12). Another obvious advantage of this
system is that it allows visualization of where the binding takes
place in live, but not fixed, cells.
During the course of studying Ras and effector binding, we
found that another constitutively active allele of H-Ras,
H-Ras(12V), bound more strongly to several effectors than
H-Ras(61L) (data not shown); thus, H-Ras(12V) was chosen
over H-Ras(61L) for this assay. In addition to H-Ras(12V), we
created a mutant Ras control, called H-RasE(12V), whose
amino acids in the effector binding region (residues 32 to 40)
were all changed to alanine. We showed that Yn-H-Ras(12V),
but not Yn-H-RasE(12V), bound the well-known Ras effec-
tors Yc-Raf-1 and RIN1-Yc (see Fig. S3 in the supplemental
material; also data not shown). Having confirmed that the
BiFC method can detect protein binding to Ras, Cdc42 was
similarly analyzed by FACS. As shown in Fig. 2A, Yc-Cdc42
bound Yn-EM-H-Ras(12V) while its binding to the Yn-EM-
H-RasE(12V) control was substantially reduced. Further-
more, as shown by microscopy (Fig. 2B), consistent with the
function of Cdc42 in regulating endocytic transport (20), the
binding between EM-H-Ras(12V) and Cdc42 can be readily
detected on endosomes but not on the Golgi apparatus. We
have similarly examined H-Ras(12V) and the effector binding
mutant control [H-RasE(12V)] and obtained similar results
(Fig. 2C and D). These data suggest that H-Ras forms a com-
plex with Cdc42, and this binding is readily detectable on
endosomes and dependent on the effector loop of H-Ras.
To validate the binding biochemically and to determine
whether it is dependent on the guanine nucleotide binding
state of Ras, we ectopically expressed a FLAG-tagged nonon-
cogenic or oncogenic constitutively GTP-bound form of
FIG. 2. H-Ras forms a complex with Cdc42 on endosomes. (A) A representative clone of HTC75 cells stably coexpressing Yc-Cdc42 and either
Yn-EM-H-Ras(12V) (green) or Yn-EM-H-RasE(12V) (white) was analyzed by FACS (top). The cells were lysed, and the protein levels were
examined by Western blotting using an anti-GFP (-GFP) antibody, which cross-reacts with YFP (bottom). (B) The same cells as in panel A were
transfected with vectors expressing either CFP-tagged Rab5A or GalT, which mark endosomes and the Golgi compartment, respectively, and
examined by confocal microscopy. YFP and CFP signals were pseudocolored green and red, and the outline of the cell was marked by a dotted
line in the merged image. Scale bar, 10 m. (C) Two clones each of HTC75 cells stably coexpressing Yc-Cdc42 and either Yn-H-Ras(12V) (green)
or Yn-H-RasE(12V) (white) were analyzed by FACS, and protein expression levels were examined by Western blotting as described for panel
A. (D) Cells in panel C were transfected with vectors expressing organelle markers and examined as described for panel B.
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EM-H-Ras together with Cdc42 and performed coimmunopre-
cipitation experiments. As shown in Fig. 3A, the oncogenic
EM-H-Ras could bring down Cdc42 approximately 5-fold
more efficiently than the nononcogenic form. The same coim-
munoprecipitation experiment was performed with the unre-
stricted oncogenic H-Ras, and the same results were obtained
(Fig. 3B). We performed the reverse coimmunoprecipitation
experiments and found that FLAG-Cdc42 also pulled down
oncogenic H-Ras more efficiently (Fig. 3C). To determine
whether the binding between endogenous Ras and Cdc42
could be readily detected, we immunoprecipitated Ras pro-
teins from HTC75 cells, which were derived from HT1080 cells
that contain an oncogenic N-RAS, and detected coimmunopre-
cipitation of endogenous Cdc42 (Fig. 3D). We conclude from
these data that Cdc42 preferentially binds H-Ras-GTP.
H-Ras and Cdc42 interaction is stimulated by EGF and
serum. Since GTP-bound H-Ras binds Cdc42 more efficiently,
we asked whether this interaction was stimulated by growth
factors that activate Ras proteins. To this end, nononcogenic
H-Ras and Cdc42 were ectopically coexpressed, and the cells
were then serum starved before being stimulated by either
epidermal growth factor (EGF) or serum. As shown in Fig. 3E,
the binding between H-Ras and Cdc42 was readily induced 5
min after EGF addition. Similar results were obtained with
cells that were stimulated by serum.
Active H-Ras can activate Cdc42 by recruiting and activat-
ing Cdc42 GEFs. To determine whether the binding of H-Ras
to Cdc42 could lead to Cdc42 activation, we carried out an
effector pulldown assay using the CRIB (Cdc42/Rac interactive
binding) domain from the Cdc42 effector PAK1, which pref-
FIG. 3. Cdc42 preferentially binds H-Ras-GTP. (A) 293FT cells were cotransfected to express FLAG-tagged EM-H-Ras or EM-H-Ras(61L)
together with Cdc42 (left). The FLAG-tagged H-Ras proteins were immunoprecipitated, and the resulting samples, together with the cell lysate
(input), were examined by Western blotting. The asterisk denotes the IgG light chain. The levels of immunoprecipitated H-Ras were used to
normalize levels of coprecipitated Cdc42. The normalized level of Cdc42 in cells that ectopically expressed the FLAG-EM-H-Ras(61L) was set to 1.
On the right, the same cells were also cotransfected to express FLAG-tagged unrestricted H-Ras(61L) (U) or PM-Ras(61L) (P), in addition to the
FLAG-tagged EM-H-Ras(61L) (E), together with Cdc42. The coimmunoprecipitation was performed as described above. (B) 293FT cells were
similarly transfected to express FLAG-tagged unrestricted wild-type or oncogenic (12V) H-Ras, together with Cdc42, and the coimmunoprecipi-
tation experiment was performed as described for panel A. Note that images were cropped from different lanes on the same Western blot
membrane. (C) 293FT cells were transfected to express FLAG-tagged Cdc42 together with GFP-tagged H-Ras or oncogenic H-Ras(12V), and
FLAG-tagged Cdc42 proteins were immunoprecipitated as described for panel A. The level of immunoprecipitated Cdc42 was used to normalize
coprecipitated H-Ras proteins. The normalized level of H-Ras(12V) was set to 1. The double asterisks denote the nonprenylated H-Ras, and the
arrowhead marks the immunoprecipitated prenylated H-Ras (19). (D) Endogenous Ras proteins of HTC75 cells were immunoprecipitated by the
Ras10 antibody, and mouse IgG was used as the antibody control. The cell lysates (input) and immunoprecipitated samples were examined by
Western blotting. (E) 293FT cells were transfected to express FLAG-tagged H-Ras and Cdc42 for 36 h. These cells were then serum starved for
16 h before being stimulated with either EGF (100 ng/ml) for the indicated time or serum (S; 10%) for 90 min. EGF or serum stimulation is
expected to induce EGFR phosphorylation, which we confirmed using Western blotting. H-Ras and Cdc42 coimmunoprecipitation was examined
as described for panel A. , anti; Ab, antibody.
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erentially binds Cdc42 in a GTP-bound state. As shown in Fig.
4A, when EM-H-Ras(61L) or the unrestricted H-Ras(61L)
was expressed, approximately 3-fold more Cdc42 was pulled
down than from control cells. These data suggest that the
binding of activated H-Ras induces Cdc42 activation.
Next, we ascertained how Ras activates Cdc42. In S. pombe, we
have shown that Ras1 activates Cdc42 by recruiting a Cdc42 GEF,
called Scd1/Ral1 (2). In mammalian cells, intersectin 1-L
(ITSN1-L) is a Cdc42 GEF (13, 57), and a shorter version of this
protein has been shown to bind Ras at the endomembrane by
fluorescence resonance energy transfer (FRET) (27). We thus
investigated as a proof of principle whether H-Ras in the GTP-
FIG. 4. Constitutively active H-Ras can efficiently activate Cdc42 by recruiting a Cdc42 GEF. (A) 293FT cells were cotransfected with a vector
control (V) or vectors expressing various H-Ras mutants (U, unrestricted; E, EM-restricted; and P, PM-restricted) together with MYC-tagged
Cdc42 for 36 h and then serum starved for 16 h before being lysed. The levels of Cdc42 in the lysates as well as in the GST-PAKCRIB pulldown
were analyzed by Western blotting. The portion of Cdc42 presumed to be GTP bound was obtained by dividing the latter by the former. The
Cdc42-GTP level in cells transfected with the vector control was defined as 1 (n  3 separate experiments). (B and C) 293FT cells were transfected
to express the indicated proteins. FLAG-tagged H-Ras(12V) (B) or ITSN1-L (C) was immunoprecipitated as described in the legend of Fig. 3A.
Note that the asterisk denotes the IgG light chain. In panel B, the arrowhead denotes the coimmunoprecipitated Dbl, and in panel C, endogenous
Cdc42 proteins were marked by an arrowhead. (D) 293FT cells were examined as described for panel A, and the Cdc42-GTP level in cells
expressing MYC-Cdc42 alone was set to 1. This experiment was performed twice and yielded the same results. (E) 293FT cells were transfected
to express either nontarget shRNA (NT) or shRNA against Dbl, together with FLAG-tagged H-Ras(12V) and Cdc42. FLAG-tagged H-Ras(12V)
was immunoprecipitated, and relative Cdc42 levels in the pulldown were quantified as described in the legend of Fig. 3A.
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bound state can form a complex with both Cdc42 and ITSN1-L.
We transiently transfected cells to express H-Ras(12V), Cdc42, or
ITSN1-L either alone or in various combinations. The data
show that immunoprecipitating H-Ras(12V) brought down
ITSN1-L and Cdc42 (Fig. 4B). Note that approximately 2-fold
more Cdc42 was coimmunoprecipitated with H-Ras(12V) when
ITSN1-L was also coexpressed, supporting the idea that the bind-
ing between activated H-Ras and Cdc42 is mediated by a Cdc42
GEF, such as ITSN1-L. In S. pombe, when Ras1 is overexpressed,
the binding between Scd1 and Cdc42 is enhanced (2). To examine
whether H-Ras can stimulate ITSN1-L and Cdc42 binding, we
analyzed how much Cdc42 was coimmunoprecipitated with
ITSN1-L as a function of Ras. As shown in Fig. 4C, the copre-
cipitation between ITSN1-L and Cdc42 was indeed enhanced by
oncogenic H-Ras but not by nononcogenic H-Ras. We note that
in this experiment, we were also able to detect the presence of
endogenous Cdc42 in the complex. The combination of unre-
stricted H-Ras(12V) (Fig. 4D) or EM-H-Ras(61L) (data not
shown) with ITSN1-L also acted synergistically to activate Cdc42,
as measured by the same CRIB pulldown assay.
While the ITSN1-L experiments support the idea that Ras
can activate Cdc42 by acting via its GEFs, ITSN1-L is ex-
pressed mostly in cells of neuronal original (14) and is not
expressed in many cells used in this study (e.g., 293FT or
HTC75 cells) (data not shown). Thus, the binding between
H-Ras and Cdc42 may be mediated by other GEFs, such as
Dbl, which is expressed in a wide range of cell lines. Our data
in Fig. 4B showed that when Dbl was overexpressed, the bind-
ing between oncogenic H-Ras and Cdc42 was also enhanced
(Fig. 4B); conversely, when Dbl expression was reduced to half
by shRNA, the binding was substantially weakened (Fig. 4E).
We conclude from these results that the interaction between
H-Ras and Cdc42 can be mediated by many Cdc42 GEFs.
Restrict H-Ras to the PM. To further investigate the idea
that the described H-Ras-Cdc42 interaction occurs selectively
on the endomembrane, we targeted H-Ras to the PM as a
control. Since endomembrane-restricted oncogenic H-Ras
proteins transform cells very efficiently, it is critical to target
H-Ras to the PM without association with internal membranes,
a criterion that is hard to meet by existing methods. For ex-
ample, a transmembrane domain from CD8 was used to target
proteins to the PM (5, 26), but substantial amounts of the
fusion proteins appear to localize also to the endomembrane
(6). Likewise, the myristoylation and palmitoylation signals in
LCK have been used for PM targeting, but Zlatkine et al. (58)
reported that an LCK-tagged soluble protein, chloramphenicol
acetyltransferase, associates not only with the PM but also with
the endomembrane, an observation that we have confirmed
(see below). Therefore, in this and in our previous S. pombe
study, we employed a PM-targeting sequence from the C ter-
minus of the Rit GTPase (called Rit-C), which is a small
GTPase without a CAAX motif that localizes to the PM with-
out detectable association with the endomembrane (21, 30).
When S. pombe Ras1 is tagged with the same sequence, the
resulting protein selectively activates the MAP kinase pathway
on the PM but not the Scd1-Cdc42 pathway on the endomem-
brane (30). To tag H-Ras with Rit-C, we first mutated the
cysteine in the CAAX box of H-Ras(61L) to serine to prevent
farnesylation (and nonspecific binding to internal membranes).
This mutant H-Ras was then tagged at its C terminus by Rit-C.
Since such modification may alter the activity of the isoform-
specific HVR, we named the resulting protein with a more
generic term, PM-Ras(61L) (see Fig. S1 in the supplemental
material). We confirmed that PM-Ras(61L) localizes to the
PM by both fluorescent protein tagging and immunostaining
using Ras-specific antibody (Fig. 5A and data not shown). The
signal of PM-Ras(61L) in the interior of the cell was barely
detectable and did not appear to colocalize with the markers of
endosomes (Fig. 5A), Golgi network (see Fig. S4A in the
supplemental material), and endoplasmic reticulum (ER) (see
Fig. S4B). Activated H-Ras is known to associate more with
bulk membrane than with lipid rafts on the PM (32). To ex-
amine this biochemically, we transiently expressed PM-
Ras(61L), and the cell lysates were fractionated by sucrose
gradient centrifugation in the presence of Na2CO3, which pre-
vents extraction of membrane-bound Ras proteins. Our data
show that, indeed, PM-Ras(61L) primarily cofractionated with
the bulk membrane marker Na/K ATPase but not with the
lipid raft marker caveolin-1 (Fig. 5B). We similarly examined
cells that coexpressed both PM-Ras(61L) and unrestricted
H-Ras(61L) and found that they cofractionated in the bulk
membrane fractions (see Fig. S4C in the supplemental mate-
rial). These data suggest that PM-Ras(61L) localizes to the PM
in a manner that is indistinguishable from that of unrestricted
H-Ras(61L).
PM-restricted active Ras efficiently activates Raf but not
Cdc42. As shown above, endomembrane-restricted H-Ras in
the GTP-bound state can efficiently activate Cdc42. We thus
FIG. 5. Targeting H-Ras to the PM. (A) NIH 3T3 cells were trans-
fected to express either YFP or YFP-tagged PM-Ras(61L), together
with CFP-tagged Rab5A, an endosome marker, and examined by con-
focal microscopy. Confocal images from the same focal plane are
shown with YFP and CFP signals pseudocolored green and red, re-
spectively. We note that the YFP-PM-Ras signal in the interior of the
cell was barely detectable and did not colocalize with that of CFP-
Rab5A. Scale bar, 10 m. (B) Cell lysates of NIH 3T3 cells containing
PM-Ras(61L) were fractionated by sucrose gradient ultracentrifuga-
tion. Western blotting was performed to detect indicated proteins.
Na/K ATPase and caveolin-1 are bulk membrane and lipid raft
markers, respectively.
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further investigated whether this activation was cell compart-
ment specific. As shown in Fig. 4A, when PM-Ras(61L) was
expressed, the level of Cdc42-GTP was not significantly differ-
ent from that of cells carrying the vector control, suggesting
that PM-Ras(61L) does not efficiently activate Cdc42. The lack
of induction of Cdc42 activation by PM-Ras appears to be
partly caused by a reduction of Cdc42 binding (Fig. 3A).
As a control, we examined whether PM-Ras(61L) can acti-
vate Raf, an event known to occur on the PM. We first exam-
ined whether PM-Ras(61L) could recruit Raf-1 to the PM by
confocal microscopy. To this end, we coexpressed YFP-tagged
PM-Ras(61L) or H-Ras(61L) as a control together with CFP-
tagged Raf-1 and measured the portion of CFP-Raf-1 on the
PM. Our data show that PM-Ras(61L) recruited Raf-1 to the
PM as efficiently as the unrestricted H-Ras(61L) (37%  3%
versus 30% 6%) (Fig. 6A). A truncated Raf-1 containing just
the Ras binding domain (RBD) was similarly examined and
yielded the same results (see Fig. S5A in the supplemental
material).
To directly measure Raf kinase activity, we coexpressed PM-
Ras(61L) or H-Ras(61L) with Raf-1 and fractionated cell ly-
sates by ultracentrifugation to obtain the soluble (S100) and
membrane (P100) fractions. The latter were further analyzed
by an in vitro MEK/Erk kinase assay system. Consistent with
the microscopy data above, PM-Ras(61L) recruited Raf-1 to
the membrane fraction as efficiently as the unrestricted
H-Ras(61L) (Fig. 6B). Furthermore, PM-Ras(61L) activated
Raf-1 kinase activity as well as H-Ras(61L) (Fig. 6C). Consis-
FIG. 6. PM-targeted active Ras efficiently activates Raf. (A) NIH 3T3 cells were cotransfected to express CFP-Raf-1, together with either
YFP-tagged H-Ras(61L) or PM-Ras(61L). Thirty-six hours after transfection, cells positive for both YFP and CFP were analyzed by confocal
microscopy. YFP and CFP signals were pseudocolored green and red. Scale bar, 10 m. The efficiency of CFP-Raf-1 recruitment to the PM in these
cells was determined by measuring the CFP-Raf-1 signal at the PM over the total CFP signal in the cell. The proportions of Raf-1 at the PM in
cells carrying H-Ras(61L) or PM-Ras(61L) were 30%  6% (n  4 cells) or 37%  3% (n  9 cells), respectively. (B) The 293FT cells were
transfected to express various H-Ras mutants for 36 h and then serum starved for 16 h before being lysed. These samples were similarly labeled
as V, U, and P as in Fig. 4A. The resulting cell lysates were fractionated into the S100 and P100 fractions after centrifugation. An equal volume
of each fraction was examined by Western blotting using the indicated antibodies. The proportions of Raf-1 in the P100 fractions are shown in the
graph (n  7 separate experiments). (C) To measure Raf-1 kinase activity, an equal amount of protein from the P100 fraction of each transfection
was added to the recombinant substrate MEK1 which, when activated, will phosphorylate recombinant Erk2, detectable by Western blotting. The
Raf-1 activity was defined by dividing the portion of Erk2 that is phosphorylated by the Raf-1 protein level. The results are presented in a graph,
with the Raf-1 activity induced by H-Ras(61L) set to 1 (n  3 separate experiments). (D) 293FT cells were transfected to express various H-Ras
mutants for 36 h and then serum starved for 16 h before being lysed. These samples were labeled as V, U, E, and P as in Fig. 4A. Cell lysates were
examined by Western blotting. The portion of Erk1/2 that is phosphorylated in cells carrying just the vector control was set to 1.
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tent with the possibility that Raf and its targets in the cell are
activated, we examined the activation of endogenous Erk
proteins in cells expressing PM-Ras(61L) or unrestricted
H-Ras(61L) and found that they were similarly phosphorylated
in both cells (Fig. 6D). In further confirmation that tagging
H-Ras by Rit-C did not fundamentally change H-Ras and
effector interactions, we performed a yeast two-hybrid assay
and found that PM-Ras(61L) bound well to Raf-1, RalGDS,
and AF6 in a manner that was indistinguishable from that of
the unrestricted H-Ras(61L) (see Fig. S5B in the supplemental
material; also data not shown). We conclude from these data
that PM-restricted active H-Ras does not efficiently activate
Cdc42 although it recruits Raf to the PM efficiently, leading to
activation of Raf and Erk1/Erk2 (Erk1/2).
PM-restricted constitutively active Ras can efficiently in-
duce senescence in human primary fibroblast cells. Constitu-
tively active Ras proteins have been shown to induce senes-
cence in human primary cells, such as BJ foreskin fibroblast
cells (51). Ras presumably does so by activating the p38 protein
kinase via the Raf/MEK/MAP kinase pathway (51). Since the
PM-restricted Ras(61L) appears to selectively activate Raf, we
investigated by Western blotting whether PM-Ras(61L) effi-
ciently induced p38 phosphorylation. As shown in Fig. 7A,
PM-Ras(61L), like H-Ras(61L), efficiently induced p38 phos-
phorylation; furthermore, these cells also appeared enlarged
and flat and expressed senescence-associated 	-Gal activity
(Fig. 7B, SA-	-Gal). Ras-induced senescence also correlated
with elevated p53 levels (42), which was also induced by PM-
Ras(61L) (Fig. 7A). These data together with the Raf activa-
tion data strongly suggest that PM-restricted active Ras can
fully activate Ras pathways, such as the Raf pathway, that are
operative on the PM.
Transiently expressed PM-targeted oncogenic Ras does not
efficiently transform cells. To assess the ability of PM-re-
stricted Ras to transform NIH 3T3 cells, we transiently ex-
pressed PM-Ras(61L) and measured focus formation. Surpris-
ingly, our data showed that PM-Ras(61L) did not efficiently
induce foci (Fig. 8A). To exclude the possibility that PM-
Ras(61L) was cleared from cells faster than normal, we com-
pared its level to that of ectopically expressed GFP and
found that they both declined at about the same rate over a
5-day period (data not shown). As mentioned above, we found
that H-Ras(12V) bound Ras effectors more strongly than
H-Ras(61L); thus, we created a PM-targeted mutant with the
12V mutation [PM-Ras(12V)], but it too failed to efficiently
induce foci (Fig. 8A). We also removed the entire HVR before
fusing H-Ras(61L) to Rit-C (see Fig. S1 in the supplemental
material) and again found that the resulting protein failed to
FIG. 7. PM-restricted activated Ras can efficiently induce senescence in human primary fibroblast cells. (A) BJ cells infected by lentiviral
vectors expressing various H-Ras mutants were serum starved and then lysed to be examined by Western blotting (top). The samples were labeled
as V, U, E, and P as in Fig. 4A. Phosphorylated p38 and p53 levels in cells carrying the vector control were set to 1, and the results are shown in
the graph at the bottom (n  3 separate experiments). (B) BJ cells infected as described for panel A were selected by zeocin and examined by
microscopy after being stained for 	-Gal activity (top). Scale bar, 40 m. The samples were similarly labeled as V, U, E, and P (see Fig. 4A). For
each sample, more than 300 cells in each experiment were scored, and the percentage (n 5 separate experiments) of senescence-associated 	-Gal
(SA-	-Gal)-positive cells is shown at the bottom.
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FIG. 8. PM-targeted oncogenic Ras does not efficiently transform NIH 3T3 cells. (A) NIH 3T3 cells were transfected to express the indicated
H-Ras mutants and examined by crystal violet staining for focus formation. The numbers of foci were counted and graphed (top), and a
representative dish of cells from each transfection is shown (bottom). Transfected cells were also analyzed for Ras protein expression levels
(marked by asterisks) by Western blotting. (B) NIH 3T3 cells transfected with a control vector or vectors expressing LCK-H-Ras(12V,181/4S) or
LCK-H-Ras(12V,181/4/6S) for 36 h were fixed and immunostained with an anti-Ras antibody. Their DNA was counterstained by DAPI. These
samples were examined by confocal microscopy, and signals corresponding to Ras and DNA were pseudocolored green and blue, respectively.
Scale bar, 10 m. The proportions of LCK-H-Ras(12V,181/4S) and LCK-H-Ras(12V,181/4/6S) on the PM, determined as described in the legend
of Fig. 6A, were 29%  4% (n  8 cells) and 42%  4% (n  8 cells), respectively. This difference is statistically significant (P  0.04). (C) NIH
3T3 cells were cotransfected with vectors to express YFP-RafRBD and the indicated H-Ras mutants and examined by confocal microscopy 36 h
posttransfection. Scale bar, 10 m. The efficiencies of YFP-RafRBD recruitment to the PM by H-Ras(61L), LCK-H-Ras(12V,181/4S), and
LCK-H-Ras(12V,181/4/6S), determined as described in the legend of Fig. 6A, were 27%  4% (n  9 cells), 21%  3% (n  14 cells), and 33% 
2% (n  20 cells), respectively. The difference in the last two values is statistically significant (P  0.004).
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readily transform cells [Fig. 8A, PM-Ras(61L)-hvr]; thus, the
extra length at the C terminus afforded by Rit-C was not the
major factor inactivating cell transformation. The Rit-C tag
was also fused to H-Ras(61L) with the normal CAAX motif,
and the resulting protein was still inefficient in transforming
these cells (data not shown). To exclude the possibility that
tagging with Rit-C fundamentally inactivates the ability of on-
coproteins to transform, we similarly tagged oncogenic Src
[Src(527F)] and found that Src(527F)–Rit-C transformed NIH
3T3 cells efficiently (see Fig. S6 in the supplemental material).
Matallanas et al. have recently similarly investigated whether
PM-restricted Ras can transform cells (26). One of the meth-
ods they used to restrict H-Ras to the PM was the aforemen-
tioned myristoylation and palmitoylation signals from LCK.
However, this method has been previously demonstrated to
cause a fusion protein to localize substantially to the endo-
membrane as well as the PM. Indeed, we confirmed that the
reported LCK-H-Ras(12V,181/4S) protein showed significant
localization in the endomembrane (Fig. 8B). We mutated the
CAAX box in this protein and found that the resulting protein
[LCK-H-Ras(12V,181/4/6S)] (see Fig. S1 in the supplemental
material) now showed more pronounced PM localization. Cu-
riously, while the original LCK-tagged H-Ras protein could
efficiently transform cells as reported, the mutated form could
no longer do so (Fig. 8A). To ascertain that the LCK-H-
Ras(12V,181/4/6S), like our PM-Ras(61L), can efficiently bind
Ras effectors on the PM, we performed the same Raf recruit-
ment assay as described earlier. Our data showed that the
LCK-H-Ras(12V,181/4/6S) recruited RafRBD to the PM more
efficiently than the original LCK-tagged H-Ras protein, which
also recruited RafRBD to the endomembrane (Fig. 8C), an
observation that is consistent with our data that it localizes to
the endomembrane, as well as the PM. Raf recruitment to the
PM is expected to induce Erk1/2 activation, and, indeed, our
data showed that LCK-H-Ras(12V,181/4/6S) also activated
Erk1/2 in the cytosol as efficiently as the original LCK-tagged
H-Ras (see Fig. S7). These observations agree with our study
of the Rit-C-tagged H-Ras protein in that the efficiency in PM
targeting inversely correlated with the ability to transform
cells.
PM-restricted oncogenic Ras synergizes with activated
Cdc42 to transform cells. PM-restricted oncogenic Ras proteins
do not efficiently transform cells in the focus formation assay,
despite the fact that they can efficiently interact with Raf. Inter-
estingly, several groups have reported that overexpressing acti-
vated Raf mutants alone can only weakly transform cells (18, 34,
35, 37, 54), and at least one such Raf mutant can synergize with
activated Cdc42 for cell transformation (54). It is possible that to
efficiently transform cells, multiple compartment-specific Ras
pathways must be activated in a concerted fashion. We thus in-
vestigated whether PM-Ras(61L) can synergize with a constitu-
tively active Cdc42 [Cdc42(12V)], which is also very weak in
transforming cells when expressed alone (50), to efficiently trans-
form cells. We created stable cell lines that expressed Cdc42(12V)
either alone or together with PM-Ras(61L). These cells were
allowed to grow beyond confluence in order to measure the ability
to overcome contact inhibition, which can be readily detected by
microscopy or by crystal violet staining. As shown in Fig. 9A, the
cells carrying a vector control could grow to confluence only as a
monolayer; similarly, the cells expressing just Cdc42(12V), as ex-
pected, did not grow substantially beyond confluence. In contrast,
cells expressing just PM-Ras(61L) appeared to be weakly trans-
formed and grew to a slightly higher density than cells carrying the
vector control or Cdc42(12V). Importantly, when PM-Ras(61L)
was coexpressed with Cdc42(12V), the resulting cells were trans-
formed to a much higher degree and formed dense layers (Fig.
9A). When these cells were diluted with untransfected cells and
replated, secondary foci could be readily detected in cells that
carried both PM-Ras(61L) and Cdc42(12V); furthermore, a sim-
ilar synergy was detected when they were seeded in soft agar for
colony formation (Fig. 9B). These data are consistent with the
model that activation of Ras pathways restricted to the PM can
act in a synergistic manner with activated Cdc42 on the endo-
membrane to promote cell transformation.
Endomembrane-restricted oncogenic H-Ras can induce tu-
mor formation. Lastly, while endomembrane-restricted onco-
genic H-Ras can induce cell transformation in vitro, whether it
can induce tumor formation in vivo has not been tested. We
thus subcutaneously injected NIH 3T3 cells that stably ex-
FIG. 9. PM-restricted activated Ras synergizes with activated
Cdc42 to transform cells. (A) NIH 3T3 cells stably expressing
Cdc42(12V) or PM-Ras(61L) either alone or in combination were
cultured to saturation and photographed after 10 days (top). Scale bar,
40 m. These cells were then stained with crystal violet to show dense
layers of cells (bottom). This experiment was performed at least twice
and yielded the same results. (B) Approximately 1  104 cells as
described in panel A were seeded in soft agar in triplicate, and colony
numbers (n  3) were counted 28 days later after MTT staining. For
secondary focus formation, 1  103 cells described in panel A were
mixed with 3  105 untransfected NIH 3T3 cells and seeded in six-well
plates in triplicate. These samples were cultured for 7 days, and the
numbers of foci (n  3) were scored after crystal violet staining.
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pressed EM-H-Ras(61L) into immunodeficient mice. As
shown in Fig. 10, in less than 10 days all injected mice pro-
duced tumors that were similar in size to those caused by
unrestricted H-Ras(61L); in contrast, injecting cells carrying
the vector control produced no detectable tumors.
DISCUSSION
One leading model suggests that Ras proteins can perform
different functions by signaling from different cell compart-
ments. However, compartment-specific Ras pathways have not
been thoroughly defined. In this study, we illustrate that upon
growth factor stimulation, H-Ras can activate Cdc42 on the
endomembrane, an activity that is critical for cell transforma-
tion. In contrast, when H-Ras is restricted to the PM, it does
not efficiently activate Cdc42 although it can efficiently activate
Raf-1 and induce senescence in human primary cells. Surpris-
ingly, while oncogenic H-Ras that is restricted to the endo-
membrane can very efficiently transform NIH 3T3 cells, PM-
restricted oncogenic Ras can do so only weakly. However,
when constitutively active forms of PM-restricted Ras and
Cdc42 are coexpressed, they work in a synergistic fashion to
efficiently transform cells. We conclude from these results that
Cdc42 is a downstream target of H-Ras on the endomembrane,
and this H-Ras-Cdc42 interaction is critical for cell transfor-
mation. However, to fully transform cells, multiple compart-
ment-specific Ras pathways may need to work in a concerted
fashion.
While H-Ras can be detected in the same protein complex
with Cdc42, this interaction may not be direct. Since such
binding leads to Cdc42 activation, it seems highly probable that
Cdc42 GEFs must be in the same complex. Our data agree
with this prediction as both DBL and ITSN1-L appear to be
recruited by H-Ras to stimulate Cdc42. The H-Ras-ITSN1-L/
Dbl-Cdc42 pathway in mammalian cells resembles the Ras1-
Scd1-Cdc42 pathway in S. pombe, suggesting that this mode of
interaction may be evolutionarily conserved.
Our BiFC data suggest that H-Ras and Cdc42 interact on
endosomes. In keeping with this possibility, Ras proteins and
Cdc42 have all been shown to localize to endosomes. Further-
more, Cdc42 is well known to regulate intracellular trafficking
such as endocytosis (13, 29), and the Ras effector, RIN1, a
GEF for Rab5, is a key regulator for endocytosis (45, 47).
RIN1 and EGF receptor (EGFR) have been shown to colo-
calize in endosomes, and we have shown that H-Ras and RIN1
can bind in endosomes (see Fig. S2B and C in the supplemen-
tal material). These results suggest that the endosome is an
authentic compartment for both H-Ras and Cdc42 signaling
although it is unclear whether these two molecules depend on
one another to localize to the endosome. Finally, ubiquityla-
tion is an important step allowing proteins to be transported
through the endosome compartments. Like H-Ras, N-Ras is
concentrated on the endomembrane; furthermore, as with H-
Ras, N-Ras can be ubiquitylated (15). Although at steady state
K-Ras is not concentrated at the endomembrane, a recent
study by Lu et al. has shown that active K-Ras proteins are
present on the endosome (24). These results suggest that
Cdc42 may also interact with N-Ras and K-Ras on endosomes.
Consistent with this idea, we found that that both N- and
K-Ras can also form a complex with Cdc42 as determined by
coimmunoprecipitation (see Fig. S8 in the supplemental ma-
terial).
To stringently test the compartmentalized Ras signaling
model, it is central to seek a method that can target Ras
proteins to the PM without significant “mislocalization” to the
endomembrane, where Ras proteins transform cells very effi-
ciently. The data from this and other studies, as discussed
earlier, suggest that PM-targeting using CD8 and LCK may be
inadequate because the resulting fusion proteins localize to not
only the PM but also the endomembrane. We also tested the
polylysine region from K-Ras4B in S. pombe and found that
the resulting fusion Ras1 protein still activates both Ras1 path-
ways in S. pombe because it can be found on both the PM and
the endomembrane (B. Onken and E. Chang, unpublished
data). Therefore, in comparison, the C terminus of Rit is a
good PM targeting signal in both yeast and mammalian cells
because it can restrict H-Ras to the PM without substantial
mislocalization to the endomembrane.
The fact that Ras targeted to the PM cannot efficiently
transform NIH 3T3 cells is counterintuitive at first glance.
One obvious interpretation of this is that the Rit-C tagging
itself somehow fundamentally weakens the ability of H-Ras
to stimulate effector pathways on the PM because electro-
static interactions in the HVR have been elegantly demon-
strated to influence how different Ras proteins associate
with microdomains (called nanoclusters) in the plasma
membrane, which in turn can impact on the interaction with
effectors (9). Our data do not support this possibility, how-
ever, since PM-Ras(61L) evidently recruits Raf to the PM
and activates the Raf-Erk pathway as efficiently as the un-
restricted H-Ras(61L). Furthermore, PM-Ras(61L) induces
senescence very efficiently in human primary cells. In con-
trast, since PM-Ras(61L) synergizes with activated Cdc42 to
more efficiently transform cells, these data support an alter-
native interpretation that multiple compartment-specific
FIG. 10. Endomembrane-restricted oncogenic H-Ras efficiently in-
duces tumor formation in nude mice. NIH 3T3 cells stably carrying
either the vector control or the vector that expresses H-Ras(61L) or
EM-H-Ras(61L) were injected subcutaneously into the flank region of
immunodeficient mice (top), with eight mice per strain of cells. The
tumor volume at 10 days postinjection is tabulated at the bottom.
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pathways, which include the endomembrane Cdc42 path-
way, must be activated together for efficient cell transfor-
mation. This conclusion is consistent with several reports in
which Ras targets, such as Raf and Cdc42, can work in
concert to transform cells (18, 34, 35, 37, 54). One obvious
caveat of restricting H-Ras to the PM by the use of the Rit
protein is that the resulting H-Ras can no longer undergo
the natural palmitoylation and depalmitoylation cycle,
which is thought to control PM targeting and internalization
of H-Ras. It is possible that some Ras-effector complexes
may need to be internalized from the PM for efficient trans-
formation, but this process is now blocked.
While oncogenic K-Ras4B can transform NIH 3T3 cells,
when it was examined side by side with oncogenic H-Ras in
transient transfection assays, we along with others (22) have
found that oncogenic H-Ras transforms cells much more effi-
ciently than oncogenic K-Ras4B. Li et al. (22) further investi-
gated the potential cause of this difference in transformation
efficiency, and they found that H-Ras appears to selectively act
through the phosphatidylinositol 3-kinase (PI3K)-AKT path-
way while K-Ras activates the Raf-MEK kinase pathway (22).
These data agree with those in our study that activation of the
Raf-Erk pathway by oncogenic PM-Ras can only weakly trans-
form NIH 3T3 cells and that oncogenic K-Ras4B is the least
efficient among the three Ras proteins tested in the binding to
Cdc42.
We caution that cell transformation induced by the
Cdc42(12V) and PM-Ras(61L) pair is weaker than that in-
duced by normal unrestricted H-Ras(61L). One interpretation
of this is that, besides Cdc42, there may be additional endo-
membrane effectors that need to be activated for more efficient
transformation. Intriguingly, Tsutsumi et al. have recently ex-
amined the binding between H-Ras and the catalytic subunit of
PI3K and found that this also occurs in endosomes (48). It is
possible that some fractions of PI3K may be activated by Ras
in the endomembrane but not the PM, as generally assumed,
during transformation. Our model may also explain why cell
transformation induced by EM-H-Ras is about 30 to 50%
weaker than that induced by unrestricted H-Ras because the
former does not efficiently activate effectors on the PM. As an
alternative, it is also possible that the tested EM-H-Ras may
not localize properly to all the endomembrane compartments
visited by normal H-Ras. One major difference between the
normal and the EM-restricted H-Ras is the lack of a palmi-
toylation site in the latter, which has long been thought to
influence only PM targeting. However, in Rocks et al. (36),
when a modified form of H-Ras that is resistant to depalmi-
toylation was injected to the cell, it associated nonspecifically
with internal membranes without being concentrated at the
Golgi compartment (36), suggesting that proper cycling be-
tween palmitoylation and depalmitoylation is important for
proper Ras localization to the endomembrane as well. The
difference in localization to the endomembrane compartments
may also partly explain the observation that the unrestricted
H-Ras binds Cdc42 more efficiently than EM-H-Ras does.
It has been well documented that Ras proteins can regulate
different pathways in different cells (43). The Ras pathways in
NIH 3T3 cells have long been used as a model system to study
Ras signaling. As such, we caution that while activating PM-
restricted Ras pathways can only weakly transform these cells,
activating these Ras pathways may be sufficient for tumorigen-
esis in other types of cells. Furthermore, in addition to trans-
formation, Ras proteins also control a wide range of activities,
and it is unclear to what extent these activities are regulated in
a cell compartment-specific manner. In fact, in this study we
show that PM-restricted Ras appears to more efficiently induce
senescence in human primary cells. Despite these caveats, our
ability to evaluate cancer risk may be improved when we can
detect where in the cell activated Ras proteins reside.
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